AI assistant
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2025
Jan 14, 2025
33882_dirs_2025-01-14_6b8de27d-2876-43c4-9d92-e17add18bd99.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2025-01-13
Reporting Person: KING THOMAS BRAXTON (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-13 | Performance Restricted Stock Unit (PRSU) | $ | A | 455000 | Acquired | 2029-01-13 | Common Stock (455000) | Direct |
| 2025-01-13 | Stock Option (right to buy) | $3.32 | A | 195000 | Acquired | 2035-01-13 | Common Stock (195000) | Direct |
Footnotes
F1: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F2: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met. The PRSUs will lapse in full if achievement of at least one of the milestones is not met.
F3: The option will vest as to 1/4 of the total award on the first anniversary of August 26, 2024, and thereafter in substantially equal monthly installments over 36 months, subject to the Reporting Person's provision of service to the Issuer on each vesting date.